Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04993781 · ClinicalTrials.gov registry record · NA
Electronic Strategies for Tailored Exercise to Prevent FallS
A NA study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 11,945
- Enrollment target
NCT04993781: Completed NA study, sponsored by Brigham and Women's Hospital.
NCT04993781 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 11,945 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (751% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04993781, a NA study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 11,945 participants
- Enrollment target
Study Summary
The objectives of this proposal are to evaluate the eSTEPS CDS (eSTEPS) in a cluster randomized controlled trial. The intervention includes the following: 1) A machine learning-based fall injury risk screening algorithm to improve traditional fall risk screening. 2) Provider BPA and/or Care Gap and Smart Set to provide CDS that helps primary care providers develop a tailored fall prevention exercise plan in the context of a Medicare Wellness Visit and 3) eSTEPS Patient App and exercise tools to provide older patients continued access to their interactive, tailored exercise plan.
Primary Outcome
To determine the effect of the eSTEPS intervention on all falls per 100 patient years
Interventions
- BEHAVIORAL eSTEPS CDS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11,945 participants |
| Start Date | 2023-06-08 |
| Est. Completion | 2025-08-31 |
| Phase | NA |
What the finished NCT04993781 record still lists
NCT04993781 is an interventional study that assigns participants to a tested intervention. Its 11,945 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (751% higher).
The record links to 0 conditions, and to 1 intervention - of which eSTEPS CDS is the first listed.
NCT04993781 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04993781 about?
NCT04993781 is a clinical study titled "Electronic Strategies for Tailored Exercise to Prevent FallS". The objectives of this proposal are to evaluate the eSTEPS CDS (eSTEPS) in a cluster randomized controlled trial. The intervention includes the following: 1) A machine learning-based fall injury risk screening algorithm to improve traditional fall risk screening. 2) Provider BPA and/or Care Gap and ...
What is the current status of trial NCT04993781?
This trial is currently completed. It is a NA study. The enrollment target is 11,945 participants. The study started on 2023-06-08. Estimated completion is 2025-08-31.
What interventions are being tested in trial NCT04993781?
The interventions under investigation include: eSTEPS CDS (BEHAVIORAL).
Who is sponsoring clinical trial NCT04993781?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04993781's enrollment target sits among peer trials
11,945 14th of 2000 higher than 1,987 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01772771 · 12,000 participants
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
- NCT04937868 · 12,000 participants
Developing a Decision Instrument to Guide Abdominal-pelvic CT Imaging of Blunt Trauma Patients
- NCT06059963 · 12,000 participants
A Prospective, Multi-center, Observational Study for Signal-C Test Evaluation
- NCT06273618 · 12,000 participants · NA
iLookOut Micro-learning to Improve Knowledge Retention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI